Merrimack Pharmaceuticals Statistics
Total Valuation
MACK has a market cap or net worth of $213.76 million. The enterprise value is $194.89 million.
| Market Cap | 213.76M |
| Enterprise Value | 194.89M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MACK has 14.53 million shares outstanding. The number of shares has increased by 5.73% in one year.
| Shares Outstanding | 14.53M |
| Shares Change (YoY) | +5.73% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 66.59% |
| Float | 9.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 43.50, with zero debt.
| Current Ratio | 43.50 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.20% and return on invested capital (ROIC) is -10.87%.
| Return on Equity (ROE) | -6.20% |
| Return on Assets (ROA) | -6.10% |
| Return on Capital (ROIC) | -10.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MACK has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.87% in the last 52 weeks. The beta is 1.43, so MACK's price volatility has been higher than the market average.
| Beta (1Y) | 1.43 |
| 52-Week Price Change | +20.87% |
| 50-Day Moving Average | 14.72 |
| 200-Day Moving Average | 13.11 |
| Relative Strength Index (RSI) | 55.36 |
| Average Volume (30 Days) | 130,246 |
Short Selling Information
The latest short interest is 722,747, so 4.97% of the outstanding shares have been sold short.
| Short Interest | 722,747 |
| Short Previous Month | 729,913 |
| Short % of Shares Out | 4.97% |
| Short % of Float | 7.69% |
| Short Ratio (days to cover) | 6.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.04M |
| Pretax Income | -1.17M |
| Net Income | -1.18M |
| EBITDA | -1.17M |
| EBIT | -1.17M |
| Earnings Per Share (EPS) | -$0.08 |
Balance Sheet
The company has $18.88 million in cash and no debt, giving a net cash position of $18.88 million or $1.30 per share.
| Cash & Cash Equivalents | 18.88M |
| Total Debt | n/a |
| Net Cash | 18.88M |
| Net Cash Per Share | $1.30 |
| Equity / Book Value | 18.75M |
| Book Value Per Share | 1.29 |
| Working Capital | 18.74M |
Cash Flow
| Operating Cash Flow | -1.52M |
| Capital Expenditures | n/a |
| Free Cash Flow | -1.52M |
| FCF Per Share | -$0.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MACK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.73% |
| Shareholder Yield | -5.73% |
| Earnings Yield | -0.55% |
| FCF Yield | -0.71% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 6, 2019. It was a forward split with a ratio of 1271:1000.
| Last Split Date | Sep 6, 2019 |
| Split Type | Forward |
| Split Ratio | 1271:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |